Lapatinib or trastuzumab plus taxane therapy for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results of NCIC CTG MA.31
- Gelmon, K.A.
- Boyle, F.M.
- Kaufman, B.
- Huntsman, D.G.
- Manikhas, A.
- Di Leo, A.
- Martin, M.
- Schwartzberg, L.S.
- Lemieux, J.
- Aparicio, S.
- Shepherd, L.E.
- Dent, S.
- Ellard, S.L.
- Tonkin, K.
- Pritchard, K.I.
- Whelan, T.J.
- Nomikos, D.
- Nusch, A.
- Coleman, R.E.
- Mukai, H.
- Tjulandin, S.
- Khasanov, R.
- Rizel, S.
- Connor, A.P.
- Santillana, S.L.
- Chapman, J.-A.W.
- Parulekar, W.R.
- Show all authors +
ISSN: 1527-7755, 0732-183X
Year of publication: 2015
Volume: 33
Issue: 14
Pages: 1574-1583
Type: Article